What it does, reaction by reaction
Phase II - Conjugation Xenobiotic & Drug Metabolism · Cytosol + ER
Substrate + PAPS -> sulfate conjugate + PAP
› Notes
High-affinity but low-capacity; saturates before glucuronidation.
Showing all 1 reactions.
What accelerates and inhibits it
Regulation is pathway-specific, so each context is listed separately
No regulation recorded for this enzyme in the source documents.
Recent literature
Europe PMC · from cache · sorted by publication date
-
1
Early-stage drug discovery in a new-generation ultrahigh-throughput mass spectrometry platform.
Morato NM, Feng Y, Chen K, Huang KH, Owen A, Caruso JV, Yang B, Kulathunga SC, Mesecar AD, Klumpp-Thomas C, R… · 2026-06-02
open access unreviewed -
2
Natural Bioactive Compounds in Polycystic Ovary Syndrome: Properties, Molecular Mechanisms, and Therapeutic Potential.
Linares R, Rosas G, Vieyra E, Chaparro A, Espinoza JA, Ramírez DLA, Silva CC, Rosas P, Macías VM, Morales-Led… · 2026-05-23
open access unreviewed -
3
Sulforaphane-Activated Functional Nucleic Acids for Cancer Therapy: Mechanisms, Delivery Strategies, and Nanomedicine Advances.
Kumar M, Ibrahim NA, Rahman SU, Wilson KAG, Eman S, Basher NS, Elfalleh W, Essa MOA, Saleh AA, Mohamed Husien… · 2026-04-30
open access unreviewed -
4
Comprehensive In Vitro Metabolic Characterization of Eudesmin in Human and Mouse Hepatocytes.
Lee MS, Kim JH, Song IS, Cho YY, Lee JY, Lee HS. · 2026-03-31
open access unreviewed -
5
Genetic Variation in <i>CYP2B6</i>, <i>UGT1A4</i> and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen.
Kruger B, Chimusa ER, Abera AB, Singh J, Shamley D, Dandara C. · 2026-03-31
open access unreviewed -
6
From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics
Tanaka M, Araujo A, Valenti V, Guiguer E, Catharin V, Gualhardi C, de Souza Bastos Mazuqueli Pereira E, de Al… · 2026-03-01
open access unreviewed -
7
Impact of genetic polymorphisms on the sulfation of dehydroepiandrosterone and 17-β estradiol by human cytosolic sulfotransferase SULT2B1a.
Alatwi E, Bairam AF. · 2025-11-05
open access unreviewed -
8
<i>SULT</i> and <i>UGT</i> Genetic Variants Modulate Side Effect Profiles in South African Breast Cancer Patients Treated with Tamoxifen.
Kruger B, Chimusa E, Abera A, Singh J, Shamley D, Dandara C. · 2026-02-24
open access unreviewed -
9
Deletion of hepatic growth hormone receptor contributes to the pathogenesis of lean MAFLD by elevating CD36.
Yu D, Yang X, Zhang X, Wang X, Pu Z, Mi A, Ran L, Zhang F, Liang B, Wu Y. · 2025-10-28
open access unreviewed -
10
Tissue-derived extracellular vesicles-mediated delivery of a hepatic enzyme living panorama (HELP) for treating multifactorial liver diseases.
Zeng X, Jiang W, He B, Li L, Wu T, Fu F, Yao H, Liao G, Wang C, Wu D. · 2026-02-27
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.